Metraipolis › archive › dc_ecbe7879988f

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42056527
DOI
10.1038/s41586-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-03T02:24:50.655Z
SHA-256 of the archived text
8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3
Stable URL of this page
https://metraipolis.com/documento/dc_ecbe7879988f

How to cite

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527 — Europe PMC (en), https://europepmc.org/article/MED/42056527 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecbe7879988f (Metraipolis archive dc_ecbe7879988f, sha256 8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3)
BibTeX
@misc{dcecbe7879988f,
  title = {Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1 — Europe PMC PMID:42056527},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42056527},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecbe7879988f; sha256 8eec3a5fa40f66863fc9a42e6d1a8ea0c07386a7d2fbce662f84bc4db544d6f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42056527. Agents can read the archived copy with the MCP tool read_document.